CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
PDL Biopharma, Inc. Company Snapshot
PDL Biopharma, Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares PDL Biopharma with three other companies in this sector in the United States: Seattle Genetics, Inc. (2015 sales of $336.80 million of which 100% was Monoclonal Drugs), Acorda Therapeutics, Inc. ($492.66 million of which 100% was Zanaflex), and BIO-TECHNE Corp ($452.25 million of which 72% was Biotechnology).

Sales Analysis. PDL Biopharma reported sales of $590.45 million for the year ending December of 2015. This represents a very small increase of 1.6% versus 2014, when the company's sales were $581.23 million. Sales at PDL Biopharma have increased during each of the previous five years (and since 2010, sales have increased a total of 71%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
PDL Biopharma, Inc.
  Stock Performance Chart for PDL Biopharma, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 2.27
(Figures in U.S. Dollars)
1 Week 0.4%   13 Weeks 14.1%  
4 Weeks -27.7%   52 Weeks -26.8%  
 
PDL Biopharma, Inc. Key Data:
  Ticker: PDLI Country: United States
  Exchanges: NAS FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 590,448,000
(Year Ending Jan 2016).
Employees: 10
  Currency: U.S. Dollars Market Cap: 375,778,070
  Fiscal Yr Ends: December Shares Outstanding: 165,541,000
  Share Type: Common Closely Held Shares: 2,286,777
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.